Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
120 participants
INTERVENTIONAL
2019-11-06
2021-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dextromethorphan Use in Multimodal Analgesia Regimens for Total Knee Arthroplasty
NCT02987920
Effect of Dexamethasone as Analgesic Treatment After Total Knee Arthroplasty
NCT05008367
Analgesia in Knee Arthroscopic Surgery
NCT02818985
Dexamethasone and Pain Following Total Knee Arthroplasty
NCT02271698
Local Infiltration Analgesia Following Total Knee Arthroplasty
NCT00799175
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group IV
Dexketoprofen 50mg is given intravenous 10 min before the start of the surgery. Local infiltration analgesia is proceeded by the surgeon with 300mg ropivacaine.
Dexketoprofen Trometamol
intravenous dexketoprofen 50mg or intrathecal
Ropivacaine Hydrochloride 7.5 MG/ML
Local Infiltration Analgesia
Group Periarticular
Dexketoprofen 50mg is given as part of the local infiltration analgesia with 300mg ropivacaine. Local infiltration analgesia is proceeded by the orthopedic surgeon.
Dexketoprofen Trometamol
intravenous dexketoprofen 50mg or intrathecal
Ropivacaine Hydrochloride 7.5 MG/ML
Local Infiltration Analgesia
Group P
Local infiltration analgesia is proceeded by the surgeon with 300mg ropivacaine.
Ropivacaine Hydrochloride 7.5 MG/ML
Local Infiltration Analgesia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexketoprofen Trometamol
intravenous dexketoprofen 50mg or intrathecal
Ropivacaine Hydrochloride 7.5 MG/ML
Local Infiltration Analgesia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* accept to enter the study
* ASA score I or II
* hospitalization for at least 2 days
Exclusion Criteria
* active gastrointestinal bleeding or other active bleeding
* history of peptic ulcer
* renal failure
* hepatic failure
* chronic heart failure
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KAT General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elena Nikolakopoulou
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Elena Nikolakopoulou
Athens, Kifissia, Greece
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.